DOI: 10.1055/s-00000094

Zeitschrift für Gastroenterologie

LinksClose Window

References

Lawitz E, Ghalib R, Rodriguez-Torres M et al.
Simeprevir plus sofosbuvir with / without ribavirin in HCV genotype 1 prior null-responder / treatment-naive patients (Cosmos study): primary endpoint (SVR12) results in patients with metavir F3–4 (Cohort 2).

Journal of Hepatology 2014;
60: S524-S524

Download Bibliographical Data

Search in:

We do not assume any responsibility for the contents of the web pages of other providers.